Pub Date : 2023-07-01DOI: 10.21608/besps.2023.213045.1144
Ghida Hassan, Marwa Tarek
{"title":"COVID 19 m-RNA (Pfizer) vaccination impairs cardiac functions in adult male rats","authors":"Ghida Hassan, Marwa Tarek","doi":"10.21608/besps.2023.213045.1144","DOIUrl":"https://doi.org/10.21608/besps.2023.213045.1144","url":null,"abstract":"","PeriodicalId":9347,"journal":{"name":"Bulletin of Egyptian Society for Physiological Sciences","volume":"92 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87745682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-07-01DOI: 10.21608/besps.2023.203879.1137
M. Allam, N. Mohamed, H. Abdallah, N. El-shaer, Mohamed Y. Salem
Background: Diabetic nephropathy (DN) is a common complication among type II diabetic patients which may lead to end stage renal disease. Oxidative stress has been found to play a part in the pathophysiology of DN. Several studies have demonstrated the effective nephroprotective role of vitamin D to counteract the progression of DN, although the exact mechanisms are not yet fully understood. Adropin release has been recently linked to be one of the vitamin D effects and was reported to exert its antioxidant effects via nuclear factor erythroid 2-related factor 2 (Nrf2). Aim: To examine the nephroprotective effects of Vitamin D focusing on adropin-Nrf2 axis as one of the possible underlying mechanisms of vitamin D in rats. Materials and Methods: Thirty two albino male adult rats were used in this experiment. Rats were randomly and equally divided into four groups:(GI) was the control, (GII) received vitamin D, (GIII) was the diabetic model, and (GIV) was the diabetes+ vitamin D group. Results: Rats that received vitamin D (0.03 µg/kg/day) for 8 weeks revealed significant lower insulin resistance and oxidative stress state, a significant improvement of kidney dysfunction that was confirmed with histopathological examinations for kidney, and significantly higher levels of serum adropin in association with a significant higher renal mRNA expression of Nrf2. Conclusion: Vitamin D administration has a renoprotective effect in DN in type II diabetic rats. The antioxidant effects of vitamin D may be in part related to the adropin- Nrf2 axis.
{"title":"Protective effect of Vitamin D against type II diabetic nephropathy in rats: a possible role of adropin","authors":"M. Allam, N. Mohamed, H. Abdallah, N. El-shaer, Mohamed Y. Salem","doi":"10.21608/besps.2023.203879.1137","DOIUrl":"https://doi.org/10.21608/besps.2023.203879.1137","url":null,"abstract":"Background: Diabetic nephropathy (DN) is a common complication among type II diabetic patients which may lead to end stage renal disease. Oxidative stress has been found to play a part in the pathophysiology of DN. Several studies have demonstrated the effective nephroprotective role of vitamin D to counteract the progression of DN, although the exact mechanisms are not yet fully understood. Adropin release has been recently linked to be one of the vitamin D effects and was reported to exert its antioxidant effects via nuclear factor erythroid 2-related factor 2 (Nrf2). Aim: To examine the nephroprotective effects of Vitamin D focusing on adropin-Nrf2 axis as one of the possible underlying mechanisms of vitamin D in rats. Materials and Methods: Thirty two albino male adult rats were used in this experiment. Rats were randomly and equally divided into four groups:(GI) was the control, (GII) received vitamin D, (GIII) was the diabetic model, and (GIV) was the diabetes+ vitamin D group. Results: Rats that received vitamin D (0.03 µg/kg/day) for 8 weeks revealed significant lower insulin resistance and oxidative stress state, a significant improvement of kidney dysfunction that was confirmed with histopathological examinations for kidney, and significantly higher levels of serum adropin in association with a significant higher renal mRNA expression of Nrf2. Conclusion: Vitamin D administration has a renoprotective effect in DN in type II diabetic rats. The antioxidant effects of vitamin D may be in part related to the adropin- Nrf2 axis.","PeriodicalId":9347,"journal":{"name":"Bulletin of Egyptian Society for Physiological Sciences","volume":"65 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73362942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-07-01DOI: 10.21608/besps.2023.209806.1142
M. Ellaithy, Sherin S Elnaidany, W. Shehata, D. Saif, S. El-Hefnawy
Background: About 30% of cases with psoriasis will suffer from psoriatic arthritis (PsA). Heritable element plays a role in PsA as different genes are involved. However, few genes are involved in both psoriasis and PsA. This study aimed to investigate the predictive value of Toll-like receptor (TLR) 4 and colony stimulating factor (CSF) 2 gene expression for early detection of axial spondyloarthritis in psoriatic patients. Methods: This study included 200 subjects; 100 psoriatic patients, subdivided into two groups; Group 1: included 66 patients with plaque psoriasis without any articular complaint, and Group 2: included 44 patients with psoriatic arthritis. Group 3 included: 100 age and sex matched healthy controls. Laboratory assessment of TLR4 and CSF2 gene expression by real time polymerase chain reaction technique, and axial joint radiological assessment by Magnetic Resonance Imaging. Results: There were significant increase of CSF2 and TLR4 gene expression levels in cases compared with controls (p <0.001) for both. Additionally, a significant rise of CSF2 and TLR4 gene expression levels in cases with psoriatic arthritis compared to cases with psoriatic skin affection only (U=2.45, p= 0.01, 3.34, p= 0.001 respectively. Receiver operating characteristic curve done for earlier detection of sub-clinical changes of axSpA regarding positive MRI results in cases with psoriasis and PsA respectively with P value <0.001. Conclusion: TLR4 and CSF2 gene expression have strong predictive value in early detection of axial SpA changes in asymptomatic and non-radiographic psoriatic patients which is equivalent and equal to the MRI predictive value.
{"title":"Study of Toll -like Receptor 4 and Colony Stimulating Factor 2 Gene Expression for Early Recognition of Axial Spondyloarthritis Changes in Psoriatic cases.","authors":"M. Ellaithy, Sherin S Elnaidany, W. Shehata, D. Saif, S. El-Hefnawy","doi":"10.21608/besps.2023.209806.1142","DOIUrl":"https://doi.org/10.21608/besps.2023.209806.1142","url":null,"abstract":"Background: About 30% of cases with psoriasis will suffer from psoriatic arthritis (PsA). Heritable element plays a role in PsA as different genes are involved. However, few genes are involved in both psoriasis and PsA. This study aimed to investigate the predictive value of Toll-like receptor (TLR) 4 and colony stimulating factor (CSF) 2 gene expression for early detection of axial spondyloarthritis in psoriatic patients. Methods: This study included 200 subjects; 100 psoriatic patients, subdivided into two groups; Group 1: included 66 patients with plaque psoriasis without any articular complaint, and Group 2: included 44 patients with psoriatic arthritis. Group 3 included: 100 age and sex matched healthy controls. Laboratory assessment of TLR4 and CSF2 gene expression by real time polymerase chain reaction technique, and axial joint radiological assessment by Magnetic Resonance Imaging. Results: There were significant increase of CSF2 and TLR4 gene expression levels in cases compared with controls (p <0.001) for both. Additionally, a significant rise of CSF2 and TLR4 gene expression levels in cases with psoriatic arthritis compared to cases with psoriatic skin affection only (U=2.45, p= 0.01, 3.34, p= 0.001 respectively. Receiver operating characteristic curve done for earlier detection of sub-clinical changes of axSpA regarding positive MRI results in cases with psoriasis and PsA respectively with P value <0.001. Conclusion: TLR4 and CSF2 gene expression have strong predictive value in early detection of axial SpA changes in asymptomatic and non-radiographic psoriatic patients which is equivalent and equal to the MRI predictive value.","PeriodicalId":9347,"journal":{"name":"Bulletin of Egyptian Society for Physiological Sciences","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88028721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-04-01DOI: 10.21608/besps.2023.201192.1136
Ayda Maryoud, Rasha Elghaba, G. Gad, S. El-Desouky, M. Adel
Objective: We aimed to investigate the potential benefits and mechanisms of vitamin B12 and folic acid supplementation in obesity. Materials and methods: Thirty two Sprague-Dawley rats were separated into four groups, eight rats each: controls were fed normal chow diet (ND), obese controls were fed high fat diet (HFD) (60% of their diet as saturated fats), vitamin B12-treated rats were fed HFD concomitant with an intraperitoneal injection of 1 mg/kg/day of vitamin B12 for 5 days in week, and folic acid-treated rats were fed HFD with a concomitant administration of 50 mg/kg day of folic acid by gastric gavage, all for 12 weeks. At the end of the experiment, behavioural tests were performed, and blood samples were gathered for lipid profiles, serum vitamin B12, folic acid, and BDNF. The hippocampus and hypothalamus were isolated for oxidative stress and BDNF testing. Results: Obese rats showed hypercholesterolemia, hypertriglyceridemia (TG), hyperleptinemia, elevated oxidative stress markers, and a decline in cognitive and behavioural test parameters. Obesity had a negative effect on BDNF levels in the blood, hypothalamus, and hippocampus, which was reversed by the administration of vitamin B12 and folic acid. Treatment with vitamin B12 resulted in a significant rise in BDNF levels, a decrease in serum total cholesterol and TG, and a significant improvement in cognitive functions and behavioural test parameters. However, while the folic acid improved cognitive function parameters and oxidative stress markers, it had no effect on the lipid profile and showed a non-significant increase in BDNF levels. Conclusions: Obesity decreased BDNF levels in the hippocampus and hypothalamus, which was reversed by vitamin B12 and folic acid treatment, they are therefore an intriguing therapeutic approach for obesity and associated cognitive decline.
{"title":"Studying the effect of vitamin B12 and folic acid on the levels of brain-derived neurotrophic factor in the blood and the brain of obese male rats.","authors":"Ayda Maryoud, Rasha Elghaba, G. Gad, S. El-Desouky, M. Adel","doi":"10.21608/besps.2023.201192.1136","DOIUrl":"https://doi.org/10.21608/besps.2023.201192.1136","url":null,"abstract":"Objective: We aimed to investigate the potential benefits and mechanisms of vitamin B12 and folic acid supplementation in obesity. Materials and methods: Thirty two Sprague-Dawley rats were separated into four groups, eight rats each: controls were fed normal chow diet (ND), obese controls were fed high fat diet (HFD) (60% of their diet as saturated fats), vitamin B12-treated rats were fed HFD concomitant with an intraperitoneal injection of 1 mg/kg/day of vitamin B12 for 5 days in week, and folic acid-treated rats were fed HFD with a concomitant administration of 50 mg/kg day of folic acid by gastric gavage, all for 12 weeks. At the end of the experiment, behavioural tests were performed, and blood samples were gathered for lipid profiles, serum vitamin B12, folic acid, and BDNF. The hippocampus and hypothalamus were isolated for oxidative stress and BDNF testing. Results: Obese rats showed hypercholesterolemia, hypertriglyceridemia (TG), hyperleptinemia, elevated oxidative stress markers, and a decline in cognitive and behavioural test parameters. Obesity had a negative effect on BDNF levels in the blood, hypothalamus, and hippocampus, which was reversed by the administration of vitamin B12 and folic acid. Treatment with vitamin B12 resulted in a significant rise in BDNF levels, a decrease in serum total cholesterol and TG, and a significant improvement in cognitive functions and behavioural test parameters. However, while the folic acid improved cognitive function parameters and oxidative stress markers, it had no effect on the lipid profile and showed a non-significant increase in BDNF levels. Conclusions: Obesity decreased BDNF levels in the hippocampus and hypothalamus, which was reversed by vitamin B12 and folic acid treatment, they are therefore an intriguing therapeutic approach for obesity and associated cognitive decline.","PeriodicalId":9347,"journal":{"name":"Bulletin of Egyptian Society for Physiological Sciences","volume":"344 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77145743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-04-01DOI: 10.21608/besps.2022.171592.1131
E. Basha, H. Faheem, H. Ibrahim, R. Ismail, Mounira Seleem, Alaa Elkordy, Haidy Khattab
Depression is a mental illness that seriously harms human health. Therefore, it is crucial to create antidepressant treatments that are effective and powerful. Fetuin-A is a multifunctional glycoprotein mainly released by hepatocytes; it has a complex role in inflammatory processes. We aimed to examine the effect of fetuin-A on lipopolysaccharide-induced depressive like behavior in rats. Forty male albino rats were randomly categorized into four groups; Group I: Control group: (saline + vehicle) for 10 days, Group II: Control treated by fetuin-A group: fetuin-A (100 mg/kg/day) for 10 days, Group III: Depression group: 0.5 mg/kg lipopolysaccharide for 10 days, Group IV: Depression treated with fetuin-A group: Lipopolysaccharide (0.5 mg/kg) for 10 days followed by fetuin-A (100 mg/kg) for 10 days. Behavioral impairments were evaluated. Brain levels of malondialdehyde (MDA) and glutathione peroxidase (GPX) were estimated. The levels of tumor necrosis factor-alpha (TNF-α), interleukin (IL) IL-6, and brain-derived neurotrophic factor (BDNF), were measured by ELISA. AMPA glutamate receptors (AMPARs GluA1&2), caspase-1 and cAMP response element-binding protein (CREB) mRNA expression by real-time PCR were done. Histopathological assessment of hippocampus was done. Our results revealed that fetuin-A effectively ameliorated LPS-induced behavioral tests impairment through increasing BDNF and CREB. Additionally, fetuin-A treatment caused a decrease in the levels of MDA, TNF-α and IL-6 together with concomitant elevation of GPX and upregulation of caspase-1 and AMPAR GluA1&2 expression. We concluded that fetuin-A ameliorates depression-like behaviors of rats by controlling the Caspase-1/BDNF/CREB Pathway signaling pathway, which may serve as a new target for treatment of depression.
{"title":"Fetuin-A Ameliorates Lipopolysaccharide-induced Depressive-Like Behavior in Rats Targeting Caspase-1/BDNF/CREB Pathway","authors":"E. Basha, H. Faheem, H. Ibrahim, R. Ismail, Mounira Seleem, Alaa Elkordy, Haidy Khattab","doi":"10.21608/besps.2022.171592.1131","DOIUrl":"https://doi.org/10.21608/besps.2022.171592.1131","url":null,"abstract":"Depression is a mental illness that seriously harms human health. Therefore, it is crucial to create antidepressant treatments that are effective and powerful. Fetuin-A is a multifunctional glycoprotein mainly released by hepatocytes; it has a complex role in inflammatory processes. We aimed to examine the effect of fetuin-A on lipopolysaccharide-induced depressive like behavior in rats. Forty male albino rats were randomly categorized into four groups; Group I: Control group: (saline + vehicle) for 10 days, Group II: Control treated by fetuin-A group: fetuin-A (100 mg/kg/day) for 10 days, Group III: Depression group: 0.5 mg/kg lipopolysaccharide for 10 days, Group IV: Depression treated with fetuin-A group: Lipopolysaccharide (0.5 mg/kg) for 10 days followed by fetuin-A (100 mg/kg) for 10 days. Behavioral impairments were evaluated. Brain levels of malondialdehyde (MDA) and glutathione peroxidase (GPX) were estimated. The levels of tumor necrosis factor-alpha (TNF-α), interleukin (IL) IL-6, and brain-derived neurotrophic factor (BDNF), were measured by ELISA. AMPA glutamate receptors (AMPARs GluA1&2), caspase-1 and cAMP response element-binding protein (CREB) mRNA expression by real-time PCR were done. Histopathological assessment of hippocampus was done. Our results revealed that fetuin-A effectively ameliorated LPS-induced behavioral tests impairment through increasing BDNF and CREB. Additionally, fetuin-A treatment caused a decrease in the levels of MDA, TNF-α and IL-6 together with concomitant elevation of GPX and upregulation of caspase-1 and AMPAR GluA1&2 expression. We concluded that fetuin-A ameliorates depression-like behaviors of rats by controlling the Caspase-1/BDNF/CREB Pathway signaling pathway, which may serve as a new target for treatment of depression.","PeriodicalId":9347,"journal":{"name":"Bulletin of Egyptian Society for Physiological Sciences","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82504181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-04-01DOI: 10.21608/besps.2022.179400.1134
Sally S. Donia, S. Saleh, F. Ahmed, D. Noya, Walaa A. Fadda, G. Amer
{"title":"Nephroprotective Effect of Estradiol and Moreinga Oleifera Extract in Ovarictomized Rat","authors":"Sally S. Donia, S. Saleh, F. Ahmed, D. Noya, Walaa A. Fadda, G. Amer","doi":"10.21608/besps.2022.179400.1134","DOIUrl":"https://doi.org/10.21608/besps.2022.179400.1134","url":null,"abstract":"","PeriodicalId":9347,"journal":{"name":"Bulletin of Egyptian Society for Physiological Sciences","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88219706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-04-01DOI: 10.21608/besps.2022.170898.1129
Angie M. Ameen, Enas S. Mostafa, Enas E Eltamany, Noha Abd El-Fadeal, Mohamed El-kherbetawy, M. Mansour
Doxorubicin (DOX) is a potent chemotherapeutic agent. Unfortunately, due to the incidence of dose-dependent cardiotoxicity, its clinical usage is hampered. Natural products are gaining popularity as a means of preventing DOX-induced cardiotoxicity. In the present study, we investigated the cardiotoxic effects of DOX and assessed the potential ameliorative effects of Achillea fragrantissima extract, its combined ethyl acetate/ n . butanol (EtOAc-Bu) fraction
{"title":"Doxorubicin-Induced Cardiotoxicity in Adult Male Albino Rats and the Ameliorative Effects of Achillea Fragrantissima Crude Extract, Its Combined Ethyl Acetate/n. Butanol Fraction, and Vitamin E","authors":"Angie M. Ameen, Enas S. Mostafa, Enas E Eltamany, Noha Abd El-Fadeal, Mohamed El-kherbetawy, M. Mansour","doi":"10.21608/besps.2022.170898.1129","DOIUrl":"https://doi.org/10.21608/besps.2022.170898.1129","url":null,"abstract":"Doxorubicin (DOX) is a potent chemotherapeutic agent. Unfortunately, due to the incidence of dose-dependent cardiotoxicity, its clinical usage is hampered. Natural products are gaining popularity as a means of preventing DOX-induced cardiotoxicity. In the present study, we investigated the cardiotoxic effects of DOX and assessed the potential ameliorative effects of Achillea fragrantissima extract, its combined ethyl acetate/ n . butanol (EtOAc-Bu) fraction","PeriodicalId":9347,"journal":{"name":"Bulletin of Egyptian Society for Physiological Sciences","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82969212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.21608/besps.2022.171402.1130
M. Aboonq, Magda H M Youssef, S. El-Kafrawy, Tamer M. Hifnawy, M. Mojaddidi, Eman A-Fadhly, S. Eltarhony, A. Elgendy, E. Eid
{"title":"Methylenetetrahydrofolate Reductase and Peroxisome Proliferator-Activated Receptor-γ Gene Polymorphisms and Risk of Obesity in Females of Madina, Saudi Arabia","authors":"M. Aboonq, Magda H M Youssef, S. El-Kafrawy, Tamer M. Hifnawy, M. Mojaddidi, Eman A-Fadhly, S. Eltarhony, A. Elgendy, E. Eid","doi":"10.21608/besps.2022.171402.1130","DOIUrl":"https://doi.org/10.21608/besps.2022.171402.1130","url":null,"abstract":"","PeriodicalId":9347,"journal":{"name":"Bulletin of Egyptian Society for Physiological Sciences","volume":"144 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76817289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.21608/besps.2022.135542.1124
Sherein F. El-sayed, Islam Wahid, I. Salem, Mona Ahmed, Reham M. Wahid
{"title":"Title: Comparison of high-protein diet versus ketogenic diet as weight reduction diets in obese rats: hepatic and metabolic effects","authors":"Sherein F. El-sayed, Islam Wahid, I. Salem, Mona Ahmed, Reham M. Wahid","doi":"10.21608/besps.2022.135542.1124","DOIUrl":"https://doi.org/10.21608/besps.2022.135542.1124","url":null,"abstract":"","PeriodicalId":9347,"journal":{"name":"Bulletin of Egyptian Society for Physiological Sciences","volume":"64 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73461733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.21608/besps.2022.167068.1128
Eman El-Tabaa, Hanem M Rabah, E. Basha, A. Eid, Dina M. Tahoon, R. Elkholy, Haidy Khattab
{"title":"Silent Information Regulator 1 Mediates Quercetin Protective Effect on Cadmium-induced Testicular Damage in Adult Male Rats","authors":"Eman El-Tabaa, Hanem M Rabah, E. Basha, A. Eid, Dina M. Tahoon, R. Elkholy, Haidy Khattab","doi":"10.21608/besps.2022.167068.1128","DOIUrl":"https://doi.org/10.21608/besps.2022.167068.1128","url":null,"abstract":"","PeriodicalId":9347,"journal":{"name":"Bulletin of Egyptian Society for Physiological Sciences","volume":"36 4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89454979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：